data
-
Spine
Mainstay Medical Announces Publication of Three-Year Clinical Trial Data from Post-Market Clinical Follow-up Registry of ReActiv8® in the United Kingdom
Further real-world evidence supporting the efficacy and use of ReActiv8® Restorative NeurostimulationTM for the treatment of intractable Chronic Low Back Pain…
Read More » -
Recon
Hip Innovation Technology Announces Positive Clinical Study Data of its Novel Reverse Hip Replacement System for the Treatment of Total Hip Arthroplasty
Data Demonstrates Excellent Fixation with a Predicted Low Risk of Revision at Ten Years Patients Report Very High Levels of Satisfaction…
Read More » -
Spine
Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial
Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent…
Read More » -
Spine
Clinical Study Demonstrates Favorable Patient Outcomes with the dualPortal® Endoscopic TLIF with dualX®, the dualLIF® System
Recent clinical study indicates positive data on Amplify Surgical’s dualLIF® System, dualPortal® Endoscopic TLIF with dualX® IRVINE, CALIF. (PRWEB) APRIL 17,…
Read More » -
Spine
SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference
CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) — SPR Therapeutics, a private medical device company focused on treating pain and improving…
Read More » -
Spine
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
Study did not achieve primary endpoint of defined improvement on standard impairment scaleInVivo to evaluate full data set and strategic…
Read More » -
Recon
Exactech Presents Latest Research Discoveries at 2023 Orthopaedic Research Society Meeting
Studies highlight solutions for shoulder and knee joint replacement surgery GAINESVILLE, FL., February 21, 2023 — (BUSINESS WIRE)–Exactech, a developer…
Read More » -
Spine
Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor
Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is…
Read More » -
Neuro
Mainstay Medical announces the release of post-marketing data from the ongoing ReActiv8®-C study in patients with chronic low back pain
New real-world findings support the effectiveness and use of ReActiv8® Restorative Neurostimulation™ to treat intractable chronic low back pain November…
Read More »